Alternative Capital Partners

You have clicked a link to access the website for the Alternative Capital Partners business.  The information on the website relates to securities and other regulated financial instruments.  Only appropriately qualified investors are eligible to invest in Insurance-Linked Securities (“ILS”) and to receive detailed documentation concerning product offerings. If you seek information about the investment management activities of Swiss Re Insurance-Linked Investment Management Ltd, please contact a representative at [email protected]

Please read the important regulatory information below and confirm your understanding of its contents.  This acceptance will allow you to proceed to the website.  Please also note that a link to risk factors associated with these products accompanies information about Alternative Capital Partners and is available for your review.

The following regulators provide information about firms and registered personnel in their respective jurisdictions.  In the U.S., the Financial Industry Regulatory Authority (“FINRA”) provides such information through its BrokerCheck tool.  You may access BrokerCheck at: http://brokercheck.finra.org.  In the UK, visit the Financial Services Register maintained by the Financial Conduct Authority (“FCA”) at http://register.fca.org.uk/.  In Luxembourg, the Commission de Surveillance du Secteur Financier (“CSSF”) website located at http://www.cssf.lu.  The FCA’s website and the CSSF’s website each contain a wide range of information of specific relevance to United Kingdom and Luxembourg investors and provide access to the Financial Services Register and the register of supervised entities in Luxembourg, respectively.

Investing in ILS involves certain risks and you should refer to the risk factors for more information.  Before entering into any financial transaction, you should ensure that you fully understand the terms, have evaluated the risks and determined that the transaction is appropriate for you in all respects.  Note that past performance is not indicative of future results. The returns or performance results may be lower than estimated herein.

The Alternative Capital Partners website is for informational purposes only and does not constitute an invitation, inducement, offer, commitment, a solicitation of an offer or commitment, or any advice or recommendation, to conclude any transaction.  While information therein has been obtained from sources believed to be reliable, Alternative Capital Partners does not represent it to be accurate or complete.  The website also includes illustrations, estimates and projections and involves significant elements of subjective judgment, assumptions and analysis.

Regulatory Information
Swiss Re Capital Markets Corporation is a member of the FINRA and the Securities Investor Protection Corporation, and is regulated by the FINRA.  Swiss Re Capital Markets Limited (Financial Services Register number 187863, VAT Registration Number 244797524) of 30 St. Mary Axe, London EC3A 8EP, is a company authorized and regulated in the conduct of its investment business in the United Kingdom by the FCA and is entered in the Financial Services Register.  Swiss Re Capital Markets Europe S.A. is registered with the Luxembourg Trade and Companies Register under number B228476, having its registered office at 2 rue Edward Steichen, L-2540 Luxembourg, and is a company supervised in Luxembourg by the CSSF and the Commissariat aux Assurances (“CAA”).  

Persons dealing with SRCML outside the United Kingdom are not covered by all the rules and regulations made for the protection of investors in the United Kingdom and may not have the right to claim through the United Kingdom’s Financial Services Compensation Scheme.

Swiss Re Capital Markets Corporation, Swiss Re Capital Markets Limited and Swiss Re Capital Markets Europe SA (collectively, “SRCM”) are all wholly owned subsidiaries of Swiss Re Ltd.  SRCM acts as initial purchaser or selling agent in connection with ILS offerings.  SRCM and its affiliates may hold positions in ILS.